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Commentary on ‘Role of bone biopsy specimen culture in the management
of diabetic foot osteomyelitis’ IJS in pressInfection superimposed on an ischaemic and/or neuropathic
foot is often the tipping point towards eventual major amputation,
with its consequent medico-social implications. A growing
evidence base supports a conservative approach to diabetic foot
infections involving bone, with prolonged antimicrobial treatment
replacing the previous gold standard of segmental amputation.1 In
that context, it appears important to isolate the organism respon-
sible for bone infection as distinct from basing the treatment plan
solely on ulcer swab results. Nonetheless, bone culture is rarely per-
formed in this patient group, even in severe case. This is due to
a dearth of evidence to support its efﬁcacy, and also because of
lingering fears regarding the possible causation of bone fractures
and exacerbation of peripheral vascular disease. Elamurugan et al.
have attempted to address the role of bone culture in this thought-
ful paper.2
The poly-microbial nature of diabetic foot infections is illus-
trated by the range of organisms cultured from both ulcer and
bone in their population. Staphylococci, streptococci, pseudomonas
and klebsiella, among others, were all frequently isolated. While
the relative preponderance of each species isolated is not
surprising, the absence of correlation between the ulcer swab and
bone culture for each patient is signiﬁcant. This is especially so
when one considers that in each infection, one organism is likely
to be dominant and targeted therapy directed against this has
been shown to give the greatest yield in terms of limb salvage.3
Depending on the patient population being treated, and geograph-
ical location, antibiotic resistance deserves further consideration
thus making focused therapy essential. As the poor correlation
between bone biopsy culture and swab results suggests, swab
results alone may not provide sufﬁcient information.
Can we thus conclude that all these patients require a bone
biopsy? The Infectious Diseases Society of America and the Inter-
national Working Group on the Diabetic Foot have issued guide-
lines regarding the antimicrobial treatment of diabetic foot
infections. Appropriate broad-spectrum antibiotic therapy is likely
to cover most of the organisms cultured from the ulcer or bone
sample. However, as already mentioned, one organism tends to
dominate and targeted therapy against this organism maximises
limb salvage whilst minimising the emergence of antibiotic resis-
tance. If swab results and bone biopsy results display poor concor-
dance, as Elamurugan et al. suggest, then bone biopsy would
appear essential. However, the majority of the patients in this
cohort (57.2%) had received antibiotic therapy before theyDOI of original article: 10.1016/j.ijsu.2010.11.011.
1743-9191/$ – see front matter  2011 Surgical Associates Ltd. Published by Elsevier Lt
doi:10.1016/j.ijsu.2011.01.005underwent biopsy. This may be responsible for the differences
observed between wound and bone cultures, not least because
of the different bone penetrance of antibiotic subtypes may have
eradicated the responsible pathogen in the superﬁcial ulcer whilst
the bone deposits were undertreated. Swabs performed before the
commencement of any antibiotics may have produced quite
different correlations with the subsequent bone biopsy. Neverthe-
less, Elamurugan and has colleagues have drawn attention to an
important issue. Without doubt, bone biopsy has in important
role to play in the management of diabetic foot osteomyelitis.
The next step must be to determine precisely when it must be
performed.
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